Skip to main content

MPT Reports Fourth Quarter and Full-Year Results

By: via Business Wire

Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPT) today announced financial and operating results for the fourth quarter and full-year ended December 31, 2025, as well as certain events occurring subsequent to quarter end.

  • Net income of $0.03 and Normalized Funds from Operations (“NFFO”) of $0.18 for the 2025 fourth quarter and net loss of ($0.46) and NFFO of $0.58 for the full-year 2025, all on a per share basis;
  • Entered into a new lease in the fourth quarter for six California hospitals formerly operated by Prospect Medical Holdings (“Prospect”) that is scheduled to ramp up to $45 million of annual rent in December 2026;
  • Completed a restructuring transaction with Vibra Healthcare (“Vibra”), resulting in a new 20-year master lease and receipt of an $18 million one-time rent payment;
  • Acquired one post-acute facility in the U.S. during the fourth quarter for approximately $32 million and one post-acute facility in Europe in February for approximately €23 million, each historically strong performers with attractive EBITDARM coverage;
  • Repurchased approximately 4.5 million shares for $23.4 million under the previously announced common stock repurchase program;
  • Declared a regular quarterly dividend of $0.09 per share in February 2026; and
  • Celebrated 20 years trading on the New York Stock Exchange and commenced trading under the ticker symbol “MPT”.

Edward K. Aldag, Jr., Chairman, President and Chief Executive Officer, said, “With our recently transitioned portfolio continuing to ramp cash rents as expected and Prospect’s bankruptcy process largely behind us, we are squarely focused on continuing to strengthen our balance sheet and position our platform for future growth. Recently, we capitalized on two highly attractive acquisition opportunities, while continuing to selectively divest assets at prices above our initial investment. We remain focused on driving pro forma annualized cash rent from our current portfolio to at least $1 billion by the end of 2026, and we are excited to demonstrate our progress throughout the year.”

Included in the financial tables accompanying this press release is information about the Company’s assets and liabilities, operating results, and reconciliations of net income (loss) to NFFO, including per share amounts, all on a basis comparable to 2024 results.

PORTFOLIO UPDATE

MPT has total assets of approximately $15 billion, including $8.9 billion of general acute facilities, $2.4 billion of behavioral health facilities and $1.7 billion of post-acute facilities. As of December 31, 2025, MPT’s portfolio included 384 properties and approximately 39,000 licensed beds leased to or mortgaged by 52 hospital operating companies across the United States as well as in the United Kingdom, Switzerland, Germany, Spain, Finland, Colombia, Italy and Portugal.

Across our portfolio, general acute care providers continue to report increasing trailing twelve month (“TTM”) EBITDARM coverage year-over-year driven by sustained volume growth in the majority of our operators. In post-acute care settings, operators continue to optimize their operations resulting in a year-over-year increase in TTM EBITDARM coverage, while our behavioral health portfolios maintain healthy TTM EBITDARM coverage.

MPT has now almost entirely resolved its exposure to Prospect’s in-court restructuring process, which commenced in January 2025. In the fourth quarter, MPT entered into a 15-year lease for its California hospitals previously leased to Prospect, which is expected to result in stabilized annual cash rent of $45 million in December 2026, in line with expected contractual rent from Prospect prior to its restructuring process. Two hospitals in Connecticut were sold in January 2026, leaving only one MPT-owned facility that is under binding agreement and is expected to sell in the first quarter of 2026.

The new tenants to which MPT transferred the operations of properties in Florida, Texas, Arizona, and Louisiana are fully current on cash rents. Excluding approximately $4 million of September rent received on October 1, 2025 from a cash-basis tenant, cash collections from these new tenants increased as expected to $22 million in the fourth quarter compared to $16 million in the third quarter.

Further, MPT completed a restructuring transaction with Vibra which included entering into a new 20-year master lease agreement, MPT’s acquisition of one post-acute property for $32 million, and receipt of an approximately $18 million one-time rent payment for past obligations which we recognized as revenue in the fourth quarter. Additionally in the fourth quarter, Select Medical began leasing one of the former Vibra properties.

OPERATING RESULTS

Net income (loss) for the fourth quarter and year ended December 31, 2025 was $17 million ($0.03 per share) and ($277 million) (($0.46) per share), respectively, compared to a net loss of ($413 million) (($0.69) per share) and ($2.4 billion) (($4.02) per share), respectively, in the year earlier periods.

NFFO for the fourth quarter and year ended December 31, 2025 was $107 million ($0.18 per share) and $346 million ($0.58 per share), respectively, compared to $108 million ($0.18 per share) and $483 million ($0.80 per share) in the year earlier periods. Fourth quarter 2025 results include approximately $4 million of September rent received on October 1, 2025 and an approximately $18 million one-time rent payment from Vibra, both recorded on cash-basis.

CONFERENCE CALL AND WEBCAST

The Company has scheduled a conference call and webcast for February 19, 2026 at 11:00 a.m. Eastern Time to present the Company’s financial and operating results for the quarter and year ended December 31, 2025. The dial-in numbers for the conference call are (800)-715-9871 (U.S.) and (646) 307-1963 (International) along with passcode 2801406. The conference call will also be available via webcast in the Investor Relations section of the Company’s website, www.mpt.com.

A telephone and webcast replay of the call will be available beginning shortly after the call’s completion. The telephone replay will be available through February 26, 2026, using dial-in numbers (800) 770-2030 (U.S. & Canada) along with passcode 2801406. The webcast replay will be available for one year following the call’s completion on the Investor Relations section of the Company’s website.

The Company’s supplemental information package for the current period will also be available on the Company’s website in the Investor Relations section.

The Company uses, and intends to continue to use, the Investor Relations page of its website, which can be found at www.mpt.com, as a means of disclosing material nonpublic information and of complying with its disclosure obligations under Regulation FD, including, without limitation, through the posting of investor presentations that may include material nonpublic information. Accordingly, investors should monitor the Investor Relations page, in addition to following our press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

About Medical Properties Trust, Inc.

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world’s largest owners of hospital real estate with 384 facilities and approximately 39,000 licensed beds in nine countries and across three continents as of December 31, 2025. MPT’s financing model facilitates acquisitions and recapitalizations, and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. For more information, please visit the Company’s website at www.mpt.com.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements can generally be identified by the use of forward-looking words such as “may”, “will”, “would”, “could”, “expect”, “intend”, “plan”, “estimate”, “target”, “anticipate”, “believe”, “objectives”, “outlook”, “guidance” or other similar words, and include statements regarding our strategies, objectives, prospects, industry, asset sales, tenant conditions and anticipated rent. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results or future events to differ materially from those expressed in or underlying such forward-looking statements, including, but not limited to: (i) the risk that projected rents may be lower than anticipated or realized later than expected; (ii) the risk that the timing, outcome and terms of the bankruptcy restructuring of Prospect will not be consistent with those anticipated by the Company; (iii) our success in implementing our business strategy and our ability to identify, underwrite, finance, consummate and integrate acquisitions and investments; (iv) the risk that previously announced or contemplated property sales, loan repayments, and other capital recycling transactions do not occur as anticipated or at all; (v) the risk that MPT is not able to attain its leverage, liquidity and cost of capital objectives within a reasonable time period or at all; (vi) MPT’s ability to obtain or modify the terms of debt financing on attractive terms or at all, as a result of changes in interest rates and other factors, which may adversely impact our ability to pay down, refinance, restructure or extend our indebtedness, including extending our 2026 credit facility, as it becomes due, or pursue acquisition and development opportunities; (vii) the ability of our tenants, operators and borrowers to satisfy their obligations under their respective contractual arrangements with us; (viii) the ability of our tenants and operators to operate profitably and generate positive cash flow, remain solvent, comply with applicable laws, rules and regulations in the operation of our properties, to deliver high-quality services, to attract and retain qualified personnel and to attract patients; (ix) the risk that we are unable to monetize our investments in certain tenants at full value within a reasonable time period or at all; (x) the risk that the operations of our tenants will be negatively impacted by changes to Medicaid funding introduced by the OBBBA; and (xi) the risks and uncertainties of litigation or other regulatory proceedings.

The risks described above are not exhaustive and additional factors could adversely affect our business and financial performance, including the risk factors discussed under the section captioned “Risk Factors” in our most recent Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q, and as may be updated in our other filings with the SEC. Forward-looking statements are inherently uncertain and actual performance or outcomes may vary materially from any forward-looking statements and the assumptions on which those statements are based. Readers are cautioned not to place undue reliance on forward-looking statements as predictions of future events. We disclaim any responsibility to update such forward-looking statements, which speak only as of the date on which they were made.

 

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

 

Consolidated Balance Sheets

 

(Amounts in thousands, except for per share data)
December 31, 2025 December 31, 2024
Assets (Unaudited) (A)
Real estate assets
Land, buildings and improvements, intangible lease assets, and other

$

12,205,687

 

$

11,259,842

 

Investment in financing leases

 

421,684

 

 

1,057,770

 

Real estate held for sale

 

-

 

 

34,019

 

Mortgage loans

 

123,651

 

 

119,912

 

Gross investment in real estate assets

 

12,751,022

 

 

12,471,543

 

Accumulated depreciation and amortization

 

(1,663,056

)

 

(1,422,948

)

Net investment in real estate assets

 

11,087,966

 

 

11,048,595

 

 
Cash and cash equivalents

 

540,859

 

 

332,335

 

Interest and rent receivables

 

19,210

 

 

36,327

 

Straight-line rent receivables

 

881,452

 

 

700,783

 

Investments in unconsolidated real estate joint ventures

 

1,399,777

 

 

1,156,397

 

Investments in unconsolidated operating entities

 

322,179

 

 

439,578

 

Other loans

 

186,292

 

 

109,175

 

Other assets

 

564,040

 

 

471,404

 

Total Assets

$

15,001,775

 

$

14,294,594

 

 
Liabilities and Equity
Liabilities
Debt, net

$

9,697,835

 

$

8,848,112

 

Accounts payable and accrued expenses

 

549,105

 

 

454,209

 

Deferred revenue

 

19,289

 

 

29,445

 

Obligations to tenants and other lease liabilities

 

128,297

 

 

129,045

 

Total Liabilities

 

10,394,526

 

 

9,460,811

 

 
Equity
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares
outstanding

 

-

 

 

-

 

Common stock, $0.001 par value. Authorized 750,000 shares; issued and
outstanding - 597,008 shares at December 31, 2025 and 600,403
shares at December 31, 2024

 

597

 

 

600

 

Additional paid-in capital

 

8,573,396

 

 

8,584,917

 

Retained deficit

 

(4,136,011

)

 

(3,658,516

)

Accumulated other comprehensive income (loss)

 

168,213

 

 

(94,272

)

Total Medical Properties Trust, Inc. stockholders' equity

 

4,606,195

 

 

4,832,729

 

 
Non-controlling interests

 

1,054

 

 

1,054

 

Total Equity

 

4,607,249

 

 

4,833,783

 

Total Liabilities and Equity

$

15,001,775

 

$

14,294,594

 

 
(A) Financials have been derived from the prior year audited financial statements.

 

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

 

Consolidated Statements of Income

(Unaudited)

 

 
(Amounts in thousands, except for per share data) For the Three Months Ended For the Twelve Months Ended
December 31, 2025 December 31, 2024 December 31, 2025 December 31, 2024
 
Revenues
Rent billed

$

212,492

 

$

166,965

 

$

736,543

 

$

719,749

 

Straight-line rent

 

35,966

 

 

43,695

 

 

152,163

 

 

163,414

 

Income from financing leases

 

9,963

 

 

9,819

 

 

39,735

 

 

63,651

 

Interest and other income

 

11,921

 

 

11,365

 

 

43,581

 

 

48,733

 

Total revenues

 

270,342

 

 

231,844

 

 

972,022

 

 

995,547

 

 
Expenses
Interest

 

132,457

 

 

101,466

 

 

510,362

 

 

417,824

 

Real estate depreciation and amortization

 

67,123

 

 

64,956

 

 

265,405

 

 

447,657

 

Property-related (A)

 

9,524

 

 

9,780

 

 

36,415

 

 

27,255

 

General and administrative

 

24,585

 

 

28,489

 

 

130,427

 

 

133,789

 

Total expenses

 

233,689

 

 

204,691

 

 

942,609

 

 

1,026,525

 

 
Other (expense) income
Gain on sale of real estate

 

1,389

 

 

3,497

 

 

5,545

 

 

478,693

 

Real estate and other impairment charges, net

 

(34,663

)

 

(386,973

)

 

(193,947

)

 

(1,825,402

)

Earnings (loss) from equity interests

 

24,138

 

 

2,923

 

 

97,851

 

 

(366,642

)

Debt refinancing and unutilized financing costs

 

-

 

 

(615

)

 

(3,629

)

 

(4,292

)

Other (including fair value adjustments on securities)

 

(1,414

)

 

(48,744

)

 

(172,552

)

 

(615,565

)

Total other expense

 

(10,550

)

 

(429,912

)

 

(266,732

)

 

(2,333,208

)

 
Income (loss) before income tax

 

26,103

 

 

(402,759

)

 

(237,319

)

 

(2,364,186

)

 
Income tax expense

 

(8,506

)

 

(9,563

)

 

(38,618

)

 

(44,101

)

 
Net income (loss)

 

17,597

 

 

(412,322

)

 

(275,937

)

 

(2,408,287

)

Net income attributable to non-controlling interests

 

(284

)

 

(526

)

 

(1,112

)

 

(1,984

)

Net income (loss) attributable to MPT common stockholders

$

17,313

 

$

(412,848

)

$

(277,049

)

$

(2,410,271

)

 
Earnings per common share - basic and diluted:
Net income (loss) attributable to MPT common stockholders

$

0.03

 

$

(0.69

)

$

(0.46

)

$

(4.02

)

 
Weighted average shares outstanding - basic

 

600,966

 

 

600,402

 

 

600,892

 

 

600,248

 

Weighted average shares outstanding - diluted

 

600,966

 

 

600,402

 

 

600,892

 

 

600,248

 

 
Dividends declared per common share

$

0.09

 

$

0.08

 

$

0.33

 

$

0.46

 

 
(A) Includes $3.0 million and $3.9 million of ground lease and other expenses (such as property taxes and insurance) paid directly by us and reimbursed by our tenants for the three months ended December 31, 2025 and 2024, respectively, and $12.3 million and $13.7 million for the twelve months ended December 31, 2025 and 2024, respectively.

 

MEDICAL PROPERTIES TRUST, INC. AND SUBSIDIARIES

 

Reconciliation of Net Income (Loss) to Funds From Operations

(Unaudited)

 

 
(Amounts in thousands, except for per share data) For the Three Months Ended For the Twelve Months Ended
December 31, 2025 December 31, 2024 December 31, 2025 December 31, 2024
 
FFO information:
Net income (loss) attributable to MPT common stockholders

$

17,313

 

$

(412,848

)

$

(277,049

)

$

(2,410,271

)

Participating securities' share in earnings

 

(292

)

 

(139

)

 

(889

)

 

(946

)

Net income (loss), less participating securities' share in earnings

$

17,021

 

$

(412,987

)

$

(277,938

)

$

(2,411,217

)

 
Depreciation and amortization

 

82,247

 

 

79,396

 

 

322,712

 

 

509,524

 

Gain on sale of real estate

 

(2,044

)

 

(3,497

)

 

(6,200

)

 

(478,693

)

Real estate impairment charges

 

18,705

 

 

300,987

 

 

145,350

 

 

980,263

 

Funds from operations

$

115,929

 

$

(36,101

)

$

183,924

 

$

(1,400,123

)

 
Other impairment charges, net

 

19,164

 

 

85,654

 

 

59,651

 

 

1,258,443

 

Litigation, bankruptcy and other costs

 

2,399

 

 

4,801

 

 

13,477

 

 

51,308

 

Share-based compensation (fair value adjustments) (A)

 

(13,703

)

 

-

 

 

(10,259

)

 

-

 

Non-cash fair value adjustments

 

(16,928

)

 

52,194

 

 

106,442

 

 

563,666

 

Tax rate changes and other

 

(261

)

 

523

 

 

(11,231

)

 

5,119

 

Debt refinancing and unutilized financing costs

 

-

 

 

615

 

 

4,273

 

 

4,292

 

Normalized funds from operations

$

106,600

 

$

107,686

 

$

346,277

 

$

482,705

 

 
Certain non-cash and related recovery information:
Share-based compensation (A)

$

8,585

 

$

2,321

 

$

36,005

 

$

32,902

 

Debt costs amortization

$

7,484

 

$

5,292

 

$

27,919

 

$

20,061

 

Non-cash rent and interest revenue (B)

$

355

 

$

-

 

$

704

 

$

-

 

Cash recoveries of non-cash rent and interest revenue (C)

$

562

 

$

542

 

$

2,182

 

$

7,382

 

Straight-line rent revenue from operating and finance leases

$

(39,065

)

$

(48,627

)

$

(164,010

)

$

(178,022

)

 
 
Per diluted share data:
Net income (loss), less participating securities' share in earnings

$

0.03

 

$

(0.69

)

$

(0.46

)

$

(4.02

)

Depreciation and amortization

 

0.13

 

 

0.14

 

 

0.54

 

 

0.86

 

Gain on sale of real estate

 

-

 

 

(0.01

)

 

(0.01

)

 

(0.80

)

Real estate impairment charges

 

0.03

 

 

0.50

 

 

0.24

 

 

1.63

 

Funds from operations

$

0.19

 

$

(0.06

)

$

0.31

 

$

(2.33

)

 
Other impairment charges, net

 

0.04

 

 

0.14

 

 

0.10

 

 

2.08

 

Litigation, bankruptcy and other costs

 

-

 

 

0.01

 

 

0.02

 

 

0.09

 

Share-based compensation (fair value adjustments) (A)

 

(0.02

)

 

-

 

 

(0.02

)

 

-

 

Non-cash fair value adjustments

 

(0.03

)

 

0.09

 

 

0.18

 

 

0.94

 

Tax rate changes and other

 

-

 

 

-

 

 

(0.02

)

 

0.01

 

Debt refinancing and unutilized financing costs

 

-

 

 

-

 

 

0.01

 

 

0.01

 

Normalized funds from operations

$

0.18

 

$

0.18

 

$

0.58

 

$

0.80

 

 
Certain non-cash and related recovery information:
Share-based compensation (A)

$

0.01

 

$

-

 

$

0.06

 

$

0.05

 

Debt costs amortization

$

0.01

 

$

0.01

 

$

0.05

 

$

0.03

 

Non-cash rent and interest revenue (B)

$

-

 

$

-

 

$

-

 

$

-

 

Cash recoveries of non-cash rent and interest revenue (C)

$

-

 

$

-

 

$

-

 

$

0.01

 

Straight-line rent revenue from operating and finance leases

$

(0.07

)

$

(0.08

)

$

(0.27

)

$

(0.30

)

Notes:

 

Investors and analysts following the real estate industry utilize funds from operations ("FFO") as a supplemental performance measure. FFO, reflecting the assumption that real estate asset values rise or fall with market conditions, principally adjusts for the effects of GAAP depreciation and amortization of real estate assets, which assumes that the value of real estate diminishes predictably over time. We compute FFO in accordance with the definition provided by the National Association of Real Estate Investment Trusts, or Nareit, which represents net income (loss) (computed in accordance with GAAP), excluding gains (losses) on sales of real estate and impairment charges on real estate assets, plus real estate depreciation and amortization, including amortization related to in-place lease intangibles, and after adjustments for unconsolidated partnerships and joint ventures.

 

In addition to presenting FFO in accordance with the Nareit definition, we disclose normalized FFO, which adjusts FFO for items that relate to unanticipated or non-core events or activities or accounting changes that, if not noted, would make comparison to prior period results and market expectations less meaningful to investors and analysts. We believe that the use of FFO, combined with the required GAAP presentations, improves the understanding of our operating results among investors and the use of normalized FFO makes comparisons of our operating results with prior periods and other companies more meaningful. While FFO and normalized FFO are relevant and widely used supplemental measures of operating and financial performance of REITs, they should not be viewed as a substitute measure of our operating performance since the measures do not reflect either depreciation and amortization costs or the level of capital expenditures and leasing costs (if any not paid by our tenants) to maintain the operating performance of our properties, which can be significant economic costs that could materially impact our results of operations. FFO and normalized FFO should not be considered an alternative to net income (loss) (computed in accordance with GAAP) as indicators of our results of operations or to cash flow from operating activities (computed in accordance with GAAP) as an indicator of our liquidity.

 

Certain line items above (such as depreciation and amortization) include our share of such income/expense from unconsolidated joint ventures. These amounts are included with all activity of our equity interests in the "Earnings (loss) from equity interests" line on the consolidated statements of income.

 

(A) Total share-based compensation expense for GAAP purposes is $(5.1) million and $25.7 million for the three and twelve months ended December 31, 2025, respectively, (including the impact from changes in estimated payouts of certain performance awards and fair value adjustments on certain awards that are to be settled in cash). Cash-settled awards are typically recorded in accordance with GAAP at fair value and measured at each balance sheet date until settlement. The resulting fluctuations, which are primarily driven by changes in our stock price rather than operational performance, can introduce significant volatility in our earnings. To enhance comparability and provide a more stable view of performance over time, NFFO reflects $13.7 million and $10.3 million of additional expense in the three and twelve months ended December 31, 2025, respectively, to arrive at total share-based compensation expense using grant date fair value for all awards (including cash-settled awards) and removing the positive impact in the period from the change in estimate of the payout of our 2023 performance awards of $8.6 million and $36.0 million for the three and twelve months ended December 31, 2025.

 

(B) Includes revenue accrued during the period but not received in cash, such as deferred rent, payment-in-kind ("PIK") interest or other accruals.

 

(C) Includes cash received to satisfy previously accrued non-cash revenue, such as the cash receipt of previously deferred rent or PIK interest.

 

Contacts

Charles Lambert
Senior Vice President of Finance & Treasurer
Medical Properties Trust, Inc.
(205) 397-8897
clambert@mpt.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.27
-0.52 (-0.25%)
AAPL  260.68
-3.67 (-1.39%)
AMD  202.23
+2.11 (1.06%)
BAC  52.60
-0.76 (-1.41%)
GOOG  303.71
-0.23 (-0.08%)
META  643.00
-0.22 (-0.03%)
MSFT  397.14
-2.46 (-0.62%)
NVDA  187.21
-0.77 (-0.41%)
ORCL  155.93
-0.24 (-0.15%)
TSLA  410.51
-0.81 (-0.20%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.